Domainex will be in attendance at Biotrinity in London this year to meet with potential partners, to discuss its internal drug discovery pipeline focussed on inflammatory and oncology disease indications.  Meetings will be available on 12th or 13th May 2015.  Please contact us or request a meeting via the Biotrinity meeting system.